Jun 28, 2024
Hereditary transthyretin-mediated amyloidosis (ATTRv amyloidosis), known as Corino de Andrade disease, is a rare neurodegenerative disorder with a significant…
Jun 27, 2024
Transthyretin cardiac amyloidosis (ATTR-CA) represents an inexorably progressive and fatal cardiomyopathy. Increased understanding of the underlying pathogenesis…
Jun 24, 2024
ABSTRACTBackgroundIn the pivotal Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis significantly reduced mortality rates, leading to…
May 06, 2024
Awareness of transthyretin amyloid cardiomyopathy (ATTR-CM) has increased over the years due to diagnostic and therapeutic developments. Timely initiation of novel…
Apr 22, 2024
Simple SummaryLight-chain (AL) amyloidosis is a rare disease similar to the more common disease, multiple myeloma (MM). Both are caused by proliferation of…
Apr 20, 2024
A 76-year-old woman was found to have abnormally enlarged and calcified bilateral axillary lymph nodes on a screening mammogram (Figure 1). These correlated with…
Apr 20, 2024
Extract A 76-year-old woman was found to have abnormally enlarged and calcified bilateral axillary lymph nodes on a screening mammogram (Figure 1). These…
Mar 29, 2024
Cardiac amyloidosis used to be considered an ultra-rare disease with no treatment options. No longer. Advances in noninvasive testing have led to greater awareness…
Mar 23, 2024
IntroductionTransthyretin amyloidosis (ATTR) is a progressive, heterogeneous rare disease manifesting as ATTR polyneuropathy (ATTR-PN), ATTR cardiomyopathy (ATTR-CM…
Mar 18, 2024
AL amyloidosis is caused by the excessive production of nonfunctional immunoglobulins, leading to the formation of amyloid fibrils that damage vital organs,…